Acromegaly Drug Market 2020 Size, Share, Global Trends, Comprehensive Research Study, Opportunities, Leading Players are Novartis AG, Chiasma, Amryt Pharma, ALLERGAN, Pfizer, Johnson & Johnson

The winning Acromegaly Drug Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of this business report include; distinct analysis of the market drivers & restraints, major market players involved like industry, detailed analysis of the market segmentation & competitive analysis. It estimates CAGR values in percentages which help to know the rise or fall occurring in the market for particular product for the specific forecast period. Global Acromegaly Drug Market report also encompasses strategic profiling of key players in the market, systematic analysis of their core competencies & draws a competitive landscape for the market.

Get FREE Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-acromegaly-drug-market&rp

The Acromegaly Drug Market report can be better employed by both traditional and new players in the industry for complete knowhow of the market. The industry analysis report brings into focus important industry trends, market size, market share estimates, and sales volume that assist industry to speculate the strategies to increase return on investment (ROI). Moreover, the market document holds a substantial importance when it is about explaining market definition, classifications, applications and engagements. With the study of competitor analysis conducted in this Acromegaly Drug Market report, industry can get fluency of the strategies of key players in the market that includes new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions.

Market Analysis: Global Acromegaly Drug Market

Global acromegaly drug market is rising gradually with a substantial CAGR of 5.10% in the forecast period of 2019-2026. This rise in market value can be attributed in increase in awareness and concerns regarding the health of patients, increasing prevalence of growth hormone disorders and high expenditure in healthcare sector.

Key Market Players

Few of the major competitors currently working in the global acromegaly drug market are Takeda Pharmaceutical Company Limited, Novartis AG, Chiasma, Inc, Crinetics Pharmaceuticals, Peptron, Daewoong. Co.LTD, Silence Therapeutic, Strongbridge Biopharma plc, Amryt Pharma plc, Foresee Pharmaceuticals Co., Ltd, Ipsen Pharma, Enesi, ALLERGAN, Bausch Health, Pfizer Inc, Johnson & Johnson Services, Inc, F. Hoffmann-La Roche Ltd., Smiths Medical, Inc., Rocket Medical plc., Novo Nordisk A/S, Sanofi, Medtronic and few among others.

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-acromegaly-drug-market&rp

Market Definition: Global Acromegaly Drug Market

Acromegaly is a rare hormonal disorder also known as gigantism. It occurs when pituitary gland releases excessive growth hormone in the body due to the tumor formation in the pituitary gland. This abnormal production of growth hormone results in the bone enlargement. It mainly affects the geriatric  population.

According to the article published in the  BioMed Central Ltd , it is estimated that total incidence population of acromegaly is  around 40 to 70 cases per million worldwide. and the prevelance is upto 100 to 130 per million. Hence with this growing cases of acromegaly worldwide will enhance the demand of the market.

Segmentation: Global Acromegaly Drug Market

Acromegaly Drug Market : By Mechanism of Action

Growth Hormone Receptor Antagonists
Dopamine Agonists
Somatostatin Analogs

Acromegaly Drug Market : By Diagnosis

Medical Imaging
Medical Laboratory Investigations

Acromegaly Drug Market : By Treatment Type

Medications
Radiation Therapy
Surgery

Acromegaly Drug Market : Drug Type

Sandostatin
Somavert
Bromocriptine
Parlodel
Octreotide
Pegvisomant
Pasireotide
Lanreotide

Acromegaly Drug Market : By Route of Administration

Oral
Intravenous
Subcutaneous
Intramuscular
Others

Acromegaly Drug Market : By End Users

Hospitals
Homecare
Specialty clinics
Surgical centers
Others

Acromegaly Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market

In June 2018, Crinetics Pharmaceuticals received an award of USD 1.30 mm from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to fund the research and development of CRN00808 for the treatment of acromegaly which will help to advance potential treatment for the patients suffering from acromegaly.

In December 2014, Novartis AG received the FDA’s approval for Signifor (pasireotide) which is a somatostatin receptor agonist. This drug is used for the treatment of acromegalic patients untreated with surgery.

Table of Contents: Acromegaly Drug Market

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-acromegaly-drug-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.